Morning Buzz: Goldman Sachs (GS), Eagle Bulk Shipping (EGLE), Netflix (NFLX), Extreme Networks (EXTR), iBio, Inc. (IBIO)

Shares of Goldman Sacsh (GS) fell around 2.7% in pre-market trading Thursday despite the firm’s Q3 earnings results surpassing Wall Street’s estimates. The investment bank said its Net income rose 48% to $2.24 billion, or $4.57 a share versus estimates of $3.21, a year earlier. CEO Lloyd Blankfein cited improved economic conditions in the U.S. among the factors contributing to Goldman’s results.

On valuation-measures, shares of The Goldman Sachs Group have a trailing-12 and forward P/E of 11.37 and 10.26, respectively. P/E to growth ratio is 1.26, while t-12 profit margin is 23.32%. EPS registers at $15.58. The company has a market cap of $81.14B and a median Wall Street price target of $185.00 with a high target of $218.00.

On trading-measure, GS has a beta of 1.79 and a short float of 2.14%. In the past 52 weeks, shares of the New York-based firm have traded between a low of $151.65 and a high of $189.50 with the 50-day MA and 200-day MA located at $182.37 and $169.63 levels, respectively.

GS currently prints a one year return of about 13.93% and a year-to-date return of around 0.98%.

Eagle Bulk Shipping (EGLE) is today’s most notable pre-market mover, up a staggering 1975.00%. The spike comes after the transporter of various bulk cargoes announced that it has successfully completed its court-approved financial restructuring, emerging with a strong balance sheet and significantly enhanced liquidity.

The company said the financial restructuring process has enabled it to reduce its debt obligations by 80%, or approximately $1 billion, as well as greatly lower its annual cash interest expense and significantly enhance liquidity.

“We are very pleased to have concluded our balance sheet restructuring, which has placed the Company in a far stronger position to compete in the cyclical shipping markets,” Sophocles N. Zoullas, Chairman and Chief Executive Officer, said in a statement.

In the past 52 weeks, shares of the New York-based company have traded between a low of $0.60 and a high of $14.35 and are now at $14.35. Shares are down 90.13% year-over-year and 85.19% year-to-date.

Update: Ticker has been halted.

Netflix, Inc. (NFLX) shares plunged more than 25% in pre-market trading Thursday after the company said subscriber gains were lighter in the third-quarter than otherwise guided 90 days ago. The streaming media giant reported $1.4 billion in revenue with an EPS of 96 cents, three cents better than estimates.

Following earnings results, Northland Securities said in a note it is maintaining its ‘Market Perform’ rating on NFLX, but lowering its 12-month base case estimate to $375 from $475. Separately, analysts at Topeka Capital said the firm will continue to support a ‘Buy’ rating on the name, though it will lower its PT to $511 from $527.

NFLX shares recently lost $117.40 to $331.19. The stock is up more than 39.45% year-over-year and has gained roughly 21.84% year-to-date. In the past 52 weeks, shares of Los Gatos, California-based company have traded between a low of $299.50 and a high of $489.29.

Extreme Networks (EXTR) – Shares sunk more than 21% after the company guided well below consensus. The tech company now expects Q1 adjusted results to range between a loss of $0.02 and breakeven per share, compared to its prior guidance of a profit in the range of $0.06 to $0.08 per share. Q1 revs are expected to range between $134.0M to $135.5M down from the co.’s prior guidance of $149M to $154M.

Following the news, analysts at Wunderlich lowered their EXTR price target to $7.00 from $9.00.

EXTR shares recently lost $0.76 to $3.00. The stock is down more than 31.88% year-over-year and has lost roughly 46.13% year-to-date. In the past 52 weeks, shares of San Jose, California-based company have traded between a low of $3.53 and a high of $8.14.

Extreme Networks has a total market cap of $366.19M.

Shares of iBio, Inc (IBIO) soared 49% in pre-market trade Thursday, after the company said it has offered to assist the U.S. government by making its proprietary antibody production technology available for emergency use with the current Ebola virus outbreak.

IBIO shares recently gained $0.70 to $2.09. In the past 52 weeks, shares of Newark, Delaware-based company have traded between a low of $0.24 and a high of $2.73. Shares are up 275.68% year-over-year and 308.82% year-to-date.

Be the first to comment

Leave a Reply

Your email address will not be published.


*